Skip to main content
. 2025 Sep 13;26(18):8924. doi: 10.3390/ijms26188924
LGSOC Low-Grade Serous Ovarian Cancer
HGSOC High-Grade Serous Ovarian Cancer
ORR Overall response rate
FAK Focal Adhesion Kinase
FAKi Focal Adhesion Kinase Inhibitor
PDX Patient-Derived Xenograft
OS Overall Survival
IC Confidence Interval